XM does not provide services to residents of the United States of America.

Lanxess flags persistent weakness, shares fall



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 3-Lanxess flags persistent weakness, shares fall</title></head><body>

Q3 sales of 1.60 bln euros miss market expectations

Q3 cash flow turns negative

Shares down as much as 5%

Expects subdued performance in Q4

Adds share move in paragraph 1,7, cash flow paragraph 2,

By Linda Pasquini and Jagoda Darlak

Nov 7 (Reuters) -Speciality chemicals maker Lanxess LXSG.DE on Thursday warned it expected a weak environment in the months ahead, sending its shares down as much as 5% after reporting third-quarter sales below analysts' expectations.

It also said its free cash flow turned negative in the July-September period at -14 million euros, a decline from the 83 million euros it reported in the second quarter.

The chemicals sector, Germany's third-largest industry that employs roughly half a million workers, continues to struggle as customers are reluctant to place new orders amid prolonged economic uncertainty that has kept raw materials and energy prices high.

"A broad-based recovery is not yet in sight,” CEO Matthias Zachert said in a statement.

Sales in the quarter remained stable at 1.60 billion euros, missing analysts' forecast of 1.66 billion.

The company confirmed its annual guidance for EBITDA pre-exceptionals to grow 10%-20% in 2024. It, however, anticipates a subdued performance in the fourth quarter due to the seasonal nature of the business.

The shares were down 4.9% to 24.42 euros at 0852 GMT.

Quarterly earnings before interest, taxes, depreciation and amortization (EBITDA) pre-exceptionals rose 45.4% to 173 million euros ($185.85 million), surpassing analysts' consensus forecast of 169 million euros in a poll by Vara Research.

The beat was driven by higher volumes, cost savings and a more efficient management of its production plants, Lanxess said.

($1 = 0.9308 euros)



Reporting by Linda Pasquini and Jagoda Darlak in Gdansk, Editing by Rachel More, Mrigank Dhaniwala, Elaine Hardcastle

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.